Maximizing Investigators' Research Award (MIRA) (R35 - Clinical Trial Optional)
HHS-NIH11
POSTED: 12/11/2025
UPDATED: 12/18/2025
DUE: 05/26/2028
The Maximizing Investigators' Research Award (MIRA) provides support for individual investigators for research within the scientific mission of NIGMS via a single grant to achieve the following:Increa...
Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)
HHS-NIH11
POSTED: 12/11/2024
UPDATED: 05/21/2025
DUE: 01/11/2026
This Notice of Funding Opportunity (NOFO) supports applications to develop and implement investigator-initiated single site clinical trials including efficacy, comparative effectiveness, pragmatic and...
Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)
HHS-NIH11
POSTED: 12/11/2024
UPDATED: 03/31/2025
DUE: 10/19/2026
The purpose of this NOFO is to enhance the capability of NCATS CTSA Program KL2 scholars and recipients of re-entry supplements supported by the CTSA Program to conduct research as they complete the t...
HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggable Proteome (R03 Clinical Trial Not Allowed)
HHS-NIH11
POSTED: 12/11/2024
UPDATED: 12/11/2024
DUE: 07/16/2026
The purpose of this notice of funding opportunity (NOFO) is to solicit applications for pilot projects to identify new druggable targets for pain within the understudied druggable proteome. Awards wil...
High Impact, Interdisciplinary Science in NIDDK Research Areas (RC2 Clinical Trial Optional)
HHS-NIH11
POSTED: 12/11/2024
UPDATED: 12/11/2024
DUE: 10/15/2027
The purpose of the High Impact, Interdisciplinary Science grants program is to support high impact ideas that may lay the foundation for new fields of investigation within the mission of NIDDK. The in...
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)
HHS-NIH11
POSTED: 12/11/2024
UPDATED: 12/11/2024
DUE: 01/07/2028
Through this engineering-oriented Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to encourage submissions of exploratory/developmental Bioengineering Research Grant ...
Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)
HHS-NIH11
POSTED: 12/11/2024
UPDATED: 05/21/2025
DUE: 01/11/2026
This Notice of Funding Opportunity (NOFO) supports applications to develop and implement a Clinical Coordinating Center (CCC) for investigator-initiated multi-site clinical trials including efficacy, ...
Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)
$650,000
HHS-NIH11
POSTED: 12/11/2024
UPDATED: 12/11/2024
DUE: 10/19/2027
The CTSA Collaborative and Innovative Acceleration Award (CCIA) aims to accelerate the pace of translational research by supporting the collaborative development, dissemination, and sustainable implem...
Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C - Clinical Trial Not Allowed)
$4,000,000
HHS-NIH11
POSTED: 12/10/2025
UPDATED: 12/10/2025
DUE: 05/26/2028
Responding to the needs of the scientific community to bolster a vibrant and sustainable research workforce, the Division of Kidney, Urologic, and Hematologic Diseases (KUH) at the National Institute ...
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
HHS-NIH11
POSTED: 12/10/2024
UPDATED: 12/10/2024
DUE: 01/07/2028
Through this engineering-oriented Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to encourage submissions of exploratory/developmental Bioengineering Research Grant ...